Oorsprong van het eerstegraads netwerk van Seonghwan Lee
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Orange Grove Bio LLC
Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation.
3
| Holding Company | Financial Conglomerates | 3 |
SV Investment Corp/US/
2
| Subsidiary | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Seonghwan Lee via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Asalyxa Bio, Inc.
Asalyxa Bio, Inc. Pharmaceuticals: MajorHealth Technology Asalyxa Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. The company is based in Southfield, MI. The company's platform technology enables the delivery of existing and novel drugs directly into over-reactive immune cells, with applications across a wide array of disease areas and conditions. The company was founded by Marc Appel, who has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
IpiNovyx Bio, Inc.
IpiNovyx Bio, Inc. Medical/Nursing ServicesHealth Services IpiNovyx Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat autoimmune and inflammatory diseases through selective inhibition of the immunoproteasome. The company is based in West Nyack, NY. The company's platform technology enables highly selective, reversible, and non-toxic inhibition of various immune cell types, with applications across a range of indications with underlying immunopathology. Orange Grove Bio (OGB) is an emerging, preclinical, capital allocation, and asset development biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company was founded by Jim Graham, and the CEO is Marc Appel. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Packaged Software | Private Equity Investor | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal | |
INHIBITOR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Hollins University Corp. | College/University | Undergraduate Degree | |
RCT BioVentures NE LLC
RCT BioVentures NE LLC Investment ManagersFinance RCT BioVentures NE LLC invests in companies located in the US and New England. The fund focuses on companies operating in the fields of life sciences and medical devices. It provides financing for early stage capital requirements with an investment size ranging from $500,000 - $750,000. | Investment Managers | President | |
GSK PLC | Pharmaceuticals: Major | Private Equity Investor | |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Maryland | College/University | Masters Business Admin | |
The Johns Hopkins University | College/University | Graduate Degree | |
KSV Global
KSV Global Investment ManagersFinance KSV Global Innovations LP provides investment services. The company was founded by Dan Gay, Jon Gay, Ted Jeong, and Spencer Nam in 2018 and is headquartered in Boston, MA. | Investment Managers | Consultant / Advisor | |
CLENE INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hyundai Venture Investment Corp.
Hyundai Venture Investment Corp. Investment ManagersFinance Hyundai Venture Investment Corp. (HVIC) is the venture capital arm of Hyundai Finance Corp., founded in 1997. The firm is headquartered in Seoul, South Korea. | Investment Managers | Private Equity Investor | |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Investment Managers | Corporate Officer/Principal | |
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Medical Specialties | Director/Board Member | |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Sales & Marketing | |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Director/Board Member | |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member | |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member | |
Good Start Genetics, Inc.
Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
Arris Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Metaxen LLC
Metaxen LLC Pharmaceuticals: MajorHealth Technology Part of Exelixis, Inc., Metaxen LLC is an American company that provides compound screening assays and compound optimization services. The company was founded by Lutz B. Giebel, Michael Jay Ross. | Pharmaceuticals: Major | Founder | |
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member | |
IVERIC BIO, INC. | Pharmaceuticals: Generic | Director/Board Member | |
Didyma LLC | Corporate Officer/Principal | ||
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Pohang University of Science & Technology | College/University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 40 |
Verenigd Koninkrijk | 3 |
Zuid-Korea | 3 |
Duitsland | 2 |
Sectoraal
Health Technology | 23 |
Consumer Services | 9 |
Finance | 8 |
Health Services | 4 |
Technology Services | 2 |
Operationeel
Director/Board Member | 18 |
Corporate Officer/Principal | 8 |
Founder | 7 |
Private Equity Investor | 6 |
Chief Executive Officer | 4 |
Sterkste connecties
Insiders | |
---|---|
Lutz B. Giebel | 21 |
Debra A. Peattie | 15 |
Tae-Heum Jeong | 11 |
Marc Appel | 3 |
Ryan Fox | 2 |
- Beurs
- Insiders
- Seonghwan Lee
- Bedrijfsconnecties